Article

Loss of RREB1 in pancreatic beta cells reduces cellular insulin content and affects…

medRxiv · 2022 · Katia K Mattis, author Nicole AJ Krentz, author Christoph Metzendorf, author Fernando Abaitua, author Aliya F Spigelman, author Han Sun, author Antje K Rottner, author Austin Bautista, author Eugenia Mazzaferro, author Marta Perez-Alcantara, author Jocelyn E Manning Fox, author Jason M Torres, author Agata Weslowska-Andersen, author Grace Z Yu, author Anubha Mahajan, author Anders Larsson, author Patrick E MacDonald, author Benjamin Davies, author Marcel den Hoed, author Anna L Gloyn, author

Key facts

Title Loss of RREB1 in pancreatic beta cells reduces cellular insulin content and affects endocrine cell gene expression
First author Katia K Mattis, author Nicole AJ Krentz, author Christoph Metzendorf, author Fernando Abaitua, author Aliya F Spigelman, author Han Sun, author Antje K Rottner, author Austin Bautista, author Eugenia Mazzaferro, author Marta Perez-Alcantara, author Jocelyn E Manning Fox, author Jason M Torres, author Agata Weslowska-Andersen, author Grace Z Yu, author Anubha Mahajan, author Anders Larsson, author Patrick E MacDonald, author Benjamin Davies, author Marcel den Hoed, author Anna L Gloyn, author
Journal medRxiv
Published Jun 8, 2022
DOI 10.1101/2022.06.04.494826
Devices mentioned K042152, K190495, K202641, K231013, K800552, K810863, K853723, K860811, K862004, K874160, K874609, K912581 and 18 more
Product codes mentioned CFN, DBM, DDG, DFZ, EPT, GCJ, GCT, GEX, HET, HJO, HLI, HLQ and 4 more

At a glance

  • 10–99 FDA submissions mentioned
  • 10–99 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature